Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co., Ltd. (NPPNY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nppny · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Nippon Shinyaku Co., Ltd.You NPPNY | $1.6B | N/A | — | — |
 China Traditional Chinese Medicine Holdings Co. Limited CHIZF | $1.4B | N/A | — | -$0.07 |
 Cosmo Pharmaceuticals N.V. CMOPF | $1.5B | N/A | — | -$0.23 |
 Evotec SE EVOTF | $1.2B | N/A | — | -$0.58 |
 Genomma Lab Internacional, S.A.B. de C.V. GNMLF | $929M | 11.58x | -13.2% | $1.65 |
 Green Thumb Industries Inc. GTBIF | $2.0B | 16.19x | +21.3% | $0.50 |
 Kissei Pharmaceutical Co., Ltd. KSPHF | $1.1B | 12.26x | -8.1% | $333.61 |
Industry Average 3 peers with valid PE | — | 13.34x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Nippon Shinyaku Co., Ltd. (NPPNY) measures how much investors pay for each dollar of the company's trailing earnings. NPPNY's current PE ratio of N/A is calculated by dividing its stock price of $6.10 by its TTM earnings per share of —.
Frequently asked questions
NPPNY pe ratio · 6 questionsNPPNY's current PE ratio is N/A as of 2026-06-10, based on a stock price of $6.10 and TTM EPS of —. Data sourced from Financial Modeling Prep via NPPNY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Nippon Shinyaku Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10